Adage Capital Partners
PMVP icon

Adage Capital Partners’s PMV Pharmaceuticals PMVP Stock Holding History

Adage Capital Partners’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16M Buy
2,360,000
+500,000
+27% +$642K ﹤0.01% 843
2026
Q1 		$2.31M Buy
+1,860,000
New +$2.37M ﹤0.01% 830
2021
Q4 		– Sell
-53,000
Closed -$1.58M – 1086
2021
Q3 		$1.58M Hold
53,000
– – ﹤0.01% 902
2021
Q2 		$1.81M Sell
53,000
-25,000
-32% -$835K ﹤0.01% 881
2021
Q1 		$2.56M Buy
+78,000
New +$3.07M 0.01% 846

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners's PMVP Position: Q2 2026 in Review

Adage Capital Partners increased its PMV Pharmaceuticals (PMVP) stake by 27% in Q2 2026, buying an estimated $642K and bringing the position to 2,360,000 shares worth $3.16M. The position accounts for ﹤0.01% of the portfolio, ranked #843.

Adage Capital Partners first reported a position in PMVP in Q1 2021 and has held it in 5 quarters since. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Adage Capital Partners held 2,360,000 shares of PMV Pharmaceuticals worth $3.16M as of Q2 2026.
  • Adage Capital Partners bought 500,000 PMV Pharmaceuticals shares in Q2 2026, an estimated $642K.
  • PMV Pharmaceuticals made up ﹤0.01% of Adage Capital Partners's portfolio in Q2 2026, its #843 holding.
  • Adage Capital Partners first reported a position in PMV Pharmaceuticals in Q1 2021 and has held it in 5 quarters since.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.